索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]孙巍,冯莉,林万鹏,等.经皮冠状动脉介入治疗后桡动脉闭塞相关危 险因素分析[J].国际心血管病杂志,2024,03:141-143.
点击复制

经皮冠状动脉介入治疗后桡动脉闭塞相关危 险因素分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年03期
页码:
141-143
栏目:
综述
出版日期:
2024-05-20

文章信息/Info

Title:
-
作者:
孙巍冯莉林万鹏杨世艺杨骄霞
157011 牡丹江医学院附属红旗医院心血管内科
Author(s):
-
关键词:
桡动脉闭塞经皮冠状动脉介入治疗危险因素
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.03.004
文献标识码:
-
摘要:
桡动脉穿刺行经皮冠状动脉介入治疗(PCI)已广泛应用于临床,桡动脉闭塞 (RAO)是其常见并发症。个体差异如高龄、女性、高血压、高血脂、高血糖、吸烟史、饮酒史, 重复经桡动脉入路,鞘管类型,鞘管滞留时间,肝素剂量和术后止血时间等均可影响桡动脉内 膜,进而导致RAO,术后早期握力锻炼可预防RAO。该文介绍PCI 后桡动脉搏动减弱或闭 塞的相关危险因素。
Abstract:
-

参考文献/References

[1] Kiang SC, Nasiri AJ, Strilaeff RR, et al. Analysis of subjective and objective screening techniques as predictors of safety for radial artery intervention[J]. Ann Vasc Surg, 2020, 65:33-39.
[2] Jirous S, Bernat I, Slezak D, et al. Post-procedural radial artery occlusion and patency detection using duplex ultrasound vs. the reverse Barbeau test[J]. Eur Heart J Suppl, 2020, 22(Suppl F):F23-F29.
[3] Dahal K, Sharma S, Yousuf A, et al. A comparison of standard versus low dose heparin on access-related complications after coronary angiography through radial access: a meta-analysis of randomized controlled trials[J]. Cardiovasc Revasc Med, 2018, 19(5 Pt B):575-579.
[4] Munir U, Khan R, Nazeer N, et al. Frequency and predictors of radial artery occlusion in patients undergoing percutaneous coronary intervention[J]. Cureus, 2022, 14(5):e25505.
[5] 郭旺苗, 任明. 高血压合并糖尿病患者血管内皮功能的相关研 究[J]. 中国现代医药杂志, 2016, 18(8):94-96.
[6] Sakai H, Ikeda S, Harada T, et al. Limitations of successive transradial approach in the same arm: the Japanese experience[J]. Catheter Cardiovasc Interv, 2001, 54(2):204-208.
[7] Wakeyama T, Ogawa H, Iwami T, et al. Distal radial arterial hypertrophy after transradial intervention: a serial intravascular ultrasound study[J]. J Cardiol, 2018, 72(6):501-505.
[8] Yonetsu T, Kakuta T, Lee T, et al. Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography[J]. Eur Heart J, 2010, 31(13):1608-1615.
[9] Wang JB, Yi CX, Zhang JM. Study on influencing factors of radial artery occlusion after repeated right radial artery coronary intervention[J]. Contrast Media Mol Imaging, 2022, 2022:9624339.
[10] Horie K, Tada N, Isawa T, et al. A randomised comparison of incidence of radial artery occlusion and symptomatic radial artery spasm associated with elective transradial coronary intervention using 6[J]. EuroIntervention, 2018, 13(17):2018-2025.
[11] Cheaito R, Benamer H, Hovasse T, et al. Feasibility and safety of transradial coronary interventions using a 6.5-F sheathless guiding catheter in patients with small radial arteries[J]. Catheter Cardiovasc Interv, 2015, 86(1):51-58.
[12] Isawa T, Horie K, Honda T, et al. Slender sheath/guiding catheter combination vs. sheathless guiding catheter for acute coronary syndrome: a Propensity-Matched analysis of the two devices[J]. J Interv Cardiol, 2020, 2020:8216831.
[13] Isawa T, Horie K, Taguri MST, et al. Access-site complications of transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: a prospective cohort study with radial ultrasound follow-up[J]. Cardiovasc Interv Ther, 2020, 35(4):343-352.
[14] Nuttall G, Burckhardt J, Hadley A, et al. Surgical and patient risk factors for severe arterial line complications in adults[J]. Anesthesiology, 2016, 124(3):590-597.
[15] Zhao L, Pang YL, Zhang HJ, et al. Different dose of heparin in preventing radial artery occlusion after transradial coronary angiography: a protocol for systematic review and meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2020, 99(46):e23227.
[16] Hahalis GN, Leopoulou M, Tsigkas G, et al. Multicenter randomized evaluation of high versus standard heparin dose on incident radial arterial occlusion after transradial coronary angiography: the SPIRIT OF Artemis study[J]. JACC Cardiovasc Interv, 2018, 11(22):2241-2250.
[17] Degirmencioglu A, Buturak A, Zencirci E, et al. Comparison of effects of low-versus high-dose heparin on access-site complications during transradial coronary angiography: a doubleblind randomized study[J]. Cardiology, 2015, 131(3):142-148.
[18] Pacchioni A, Ferro J, Pesarini G, et al. The activated clotting time paradox: relationship between activated clotting time and occlusion of the radial artery when used as vascular access for percutaneous coronary procedures[J]. Circ Cardiovasc Interv, 2019, 12(9):e008045.
[19] Pancholy S, Coppola J, Patel T, et al. Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization[J]. Catheter Cardiovasc Interv, 2008, 72(3):335-340.
[20] Sanghvi KA, Montgomery M, Varghese V. Effect of hemostatic device on radial artery occlusion: a randomized comparison of compression devices in the radial hemostasis study[J]. Cardiovasc Revasc Med, 2018, 19(8):934-938.
[21] Pancholy SB, Bernat I, Bertrand OF, et al. Prevention of radial artery occlusion after transradial catheterization: the PROPHET-Ⅱ randomized trial[J]. JACC Cardiovasc Interv, 2016, 9(19):1992-1999.
[22] Shroff AR, Fernandez C, Vidovich MI, et al. Contemporary transradial access practices: results of the second international survey[J]. Catheter Cardiovasc Interv, 2019, 93(7):1276-1287.
[23] 庄燕, 俞家顺, 李晓静. 经桡动脉冠状动脉介入术后早期握 力锻炼对预防桡动脉闭塞的研究[J]. 山西医药杂志, 2022, 51(5):487-491.
[24] Wu XL, Wang JJ, Yuan DQ, et al. Ultrasound-guided radial artery catheterization at different sites: a prospective and randomized study[J]. Eur Rev Med Pharmacol Sci, 2022, 26(2):415-421.

备注/Memo

备注/Memo:
通信作者:杨骄霞, E-mail:jiaoxiayang1977@163.com
更新日期/Last Update: 2024-05-20